These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38372755)

  • 21. 6-shogaol against 3-Nitropropionic acid-induced Huntington's disease in rodents: Based on molecular docking/targeting pro-inflammatory cytokines/NF-κB-BDNF-Nrf2 pathway.
    Jambi EJ; Alamri A; Afzal M; Al-Abbasi FA; Al-Qahtani SD; Almalki NAR; Bawadood AS; Alzarea SI; Sayyed N; Kazmi I
    PLoS One; 2024; 19(7):e0305358. PubMed ID: 39008492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inosine attenuates 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats via the activation of the A2AR/BDNF/TrKB/ERK/CREB signaling pathway.
    El-Shamarka ME; El-Sahar AE; Saad MA; Assaf N; Sayed RH
    Life Sci; 2022 Jul; 300():120569. PubMed ID: 35472453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.
    Hariharan A; Shetty S; Shirole T; Jagtap AG
    Neurotoxicology; 2014 Dec; 45():139-48. PubMed ID: 25445565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Huntington's Effect of Rosiridin via Oxidative Stress/AchE Inhibition and Modulation of Succinate Dehydrogenase, Nitrite, and BDNF Levels against 3-Nitropropionic Acid in Rodents.
    Afzal M; Sayyed N; Alharbi KS; Alzarea SI; Alshammari MS; Alomar FA; Alenezi SK; Quazi AM; Alzarea AI; Kazmi I
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 35892333
    [No Abstract]   [Full Text] [Related]  

  • 25. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P; Kumar A
    Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease.
    Islam MR; Jony MH; Thufa GK; Akash S; Dhar PS; Rahman MM; Afroz T; Ahmed M; Hemeg HA; Rauf A; Thiruvengadam M; Venkidasamy B
    Mol Neurobiol; 2024 Mar; 61(3):1237-1270. PubMed ID: 37698833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair-Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax-Bad genes in male wistar rats.
    Thangarajan S; Ramachandran S; Krishnamurthy P
    Biomed Pharmacother; 2016 Dec; 84():514-525. PubMed ID: 27690136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of mGlu5 receptor in 3-nitropropionic acid-induced oxidative stress in rat striatum.
    Souza LC; Wilhelm EA; Bortolatto CF; Nogueira CW; Boeira SP; Jesse CR
    Neurol Res; 2014 Sep; 36(9):833-40. PubMed ID: 24588139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations.
    Binawade Y; Jagtap A
    J Med Food; 2013 Oct; 16(10):934-43. PubMed ID: 24138168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease.
    Gao Y; Chu SF; Li JP; Zhang Z; Yan JQ; Wen ZL; Xia CY; Mou Z; Wang ZZ; He WB; Guo XF; Wei GN; Chen NH
    Acta Pharmacol Sin; 2015 Mar; 36(3):311-22. PubMed ID: 25640478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats.
    Colle D; Santos DB; Moreira EL; Hartwig JM; dos Santos AA; Zimmermann LT; Hort MA; Farina M
    PLoS One; 2013; 8(6):e67658. PubMed ID: 23799154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymoquinone loaded solid lipid nanoparticles counteracts 3-Nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington's disease.
    Ramachandran S; Thangarajan S
    Metab Brain Dis; 2018 Oct; 33(5):1459-1470. PubMed ID: 29855977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's Disease.
    Chakraborty J; Singh R; Dutta D; Naskar A; Rajamma U; Mohanakumar KP
    CNS Neurosci Ther; 2014 Jan; 20(1):10-9. PubMed ID: 24188794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-Pinene Alleviates Motor Activity in Animal Model of Huntington's Disease via Enhancing Antioxidant Capacity.
    Rahmani H; Moloudi MR; Hashemi P; Hassanzadeh K; Izadpanah E
    Neurochem Res; 2023 Jun; 48(6):1775-1782. PubMed ID: 36689085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington's Disease.
    Fotoohi A; Moloudi MR; Hosseini S; Hassanzadeh K; Feligioni M; Izadpanah E
    Neurochem Res; 2021 Jun; 46(6):1372-1379. PubMed ID: 33611726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease.
    Kumar P; Kalonia H; Kumar A
    Behav Pharmacol; 2010 May; 21(3):217-30. PubMed ID: 20480544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective potential of antioxidant potent fractions from Convolvulus pluricaulis Chois. in 3-nitropropionic acid challenged rats.
    Kaur M; Prakash A; Kalia AN
    Nutr Neurosci; 2016; 19(2):70-8. PubMed ID: 25896328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
    Colle D; Hartwig JM; Soares FA; Farina M
    Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
    Tadros MG; Khalifa AE; Abdel-Naim AB; Arafa HM
    Pharmacol Biochem Behav; 2005 Nov; 82(3):574-82. PubMed ID: 16337998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences.
    Kumar A; Chaudhary T; Mishra J
    Eur J Pharmacol; 2013 Nov; 720(1-3):16-28. PubMed ID: 24211676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.